Literature DB >> 15494677

[Intrathoracic omentoplasty in the treatment of pleural cavity secondary to stabilized bronchial fistula].

L Politi1, P Scanagatta, A Salani, F Montinaro, A Turini, C Crisci.   

Abstract

AIM: The aim of this paper was to verify the effectiveness of omentoplasty, either single or associated to other procedures, in the treatment of permanent fistula of the main bronchi.
METHODS: The authors report their experience of 10 intrathoracic omentoplasties for pleural cavity from fistula of the main bronchus. In 2 cases a single omentoplasty was performed, while 8 patients had an associated procedure (4 thoracoplasties, 7 mioplasties and 2 mammoplasties). In 8 cases the vascular pedicle used for the omentum was the right gastroepiploic artery, and the left one in the remaining 2 patients. The omentum was mobilized through an opening in the diaphragm and anchored to the bronchial stump. In the combined plasties it was then covered by chest wall (thoracoplasty), muscles (mioplasty) or mammary gland (mammoplasty); in the single omentoplasty omentum was also sutured to the chest wall. Indication for combined procedures was high bacterial contamination of the pleural cavity; single omentoplasty was performed for small cavities, where other procedures had previously failed. Only in the single omentoplasties a pre-operative selective angiography of the gastroepiploic arteries was performed.
RESULTS: Such procedures were resolutive in 9 patients; 1 needed an endoscopic application of fibrin glue.
CONCLUSION: Intrathoracic omentoplasty is an effective procedure to solve both pleural cavity and stabilized bronchial fistula, mostly because of plastic and immunologic features of the omentum.

Entities:  

Mesh:

Year:  2004        PMID: 15494677

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  1 in total

Review 1.  Current indications for the intrathoracic transposition of the omentum.

Authors:  Petre V H Botianu
Journal:  J Cardiothorac Surg       Date:  2019-06-10       Impact factor: 1.637

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.